[HTML][HTML] Yttrium‐90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study
Conclusions Despite clear relationships between HBV RNA and HBcrAg levels and CHB
phases, these markers have limited additional value in differentiating CHB phases because …
phases, these markers have limited additional value in differentiating CHB phases because …
Tailoring radiotherapies and nanotechnology for targeted treatment of solid tumors
Existing anticancer therapeutic modalities in clinical settings lack efficacy and fail to
completely cure cancers. Clearly understandable and mechanistic approaches are …
completely cure cancers. Clearly understandable and mechanistic approaches are …
Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?
In this debate, the authors consider whether patients with hepatocellular carcinoma (HCC)
and portal vein tumour thrombosis are candidates for liver transplantation (LT). The …
and portal vein tumour thrombosis are candidates for liver transplantation (LT). The …
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group
R Salem, SA Padia, M Lam, J Bell, C Chiesa… - European journal of …, 2019 - Springer
Abstract The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by
BTG International to review existing data and address gaps in knowledge related to …
BTG International to review existing data and address gaps in knowledge related to …
[HTML][HTML] Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an …
R Salem, SA Padia, M Lam, C Chiesa, P Haste… - European Journal of …, 2023 - Springer
Purpose In light of recently published clinical reports and trials, the TheraSphere Global
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …
[HTML][HTML] Clinical application of trans-arterial radioembolization in hepatic malignancies in Europe: first results from the prospective multicentre observational study …
T Helmberger, R Golfieri, M Pech, T Pfammatter… - Cardiovascular and …, 2021 - Springer
Purpose To address the lack of prospective data on the real-life clinical application of trans-
arterial radioembolization (TARE) in Europe, the Cardiovascular and Interventional …
arterial radioembolization (TARE) in Europe, the Cardiovascular and Interventional …
Characterization of response to atezolizumab+ bevacizumab versus sorafenib for hepatocellular carcinoma: Results from the IMbrave150 trial
R Salem, D Li, N Sommer, S Hernandez… - Cancer …, 2021 - Wiley Online Library
Background IMbrave150 is a phase III trial that assessed atezolizumab+ bevacizumab
(ATEZO/BEV) versus sorafenib (SOR) in patients with unresectable hepatocellular …
(ATEZO/BEV) versus sorafenib (SOR) in patients with unresectable hepatocellular …
[HTML][HTML] Contemporary applications of Y90 for the treatment of hepatocellular carcinoma
Q Yu, M Khanjyan, N Fidelman… - Hepatology …, 2023 - journals.lww.com
Transarterial radioembolization (TARE) with yttrium-90 (90 Y) microspheres has been widely
adopted for the treatment of HCC. Recent advances in yttrium-90 (90 Y) dosimetry have led …
adopted for the treatment of HCC. Recent advances in yttrium-90 (90 Y) dosimetry have led …
Comparing real world, personalized, multidisciplinary tumor board recommendations with BCLC algorithm: 321-patient analysis
MM Matsumoto, S Mouli, P Saxena, A Gabr… - CardioVascular and …, 2021 - Springer
Purpose To evaluate hepatocellular carcinoma (HCC) treatment allocation, deviation from
BCLC first-treatment recommendation, and outcomes following multidisciplinary …
BCLC first-treatment recommendation, and outcomes following multidisciplinary …
[HTML][HTML] Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs. 125Iodine Implantation
HT Hu, JP Luo, GS Cao, Z Li, M Jiang, CY Guo… - Frontiers in …, 2021 - frontiersin.org
Background and Aims This study investigated the feasibility, safety, and efficacy of
transarterial chemoembolization (TACE) combined with CT-guided 125iodine seed …
transarterial chemoembolization (TACE) combined with CT-guided 125iodine seed …